Concepedia

Publication | Open Access

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients

23

Citations

19

References

2022

Year

References

YearCitations

Page 1